I

Intarcia Therapeutics, Inc.

82 employees

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Health Diagnostics
Personal Health
Health Care

Date founded

1997

Funding rounds raised

Total raised

$215M

from 23 investors over 23 rounds

I

Intarcia Therapeutics, Inc. raised undisclosed on August 29, 2019

Investors: GGV Capital

I

Intarcia Therapeutics, Inc. raised $206M on December 29, 2016

Investors: Bill & Melinda Gates Foundation and GWC Innovator Fund

I

Intarcia Therapeutics, Inc. raised $215M on September 15, 2016

Investors: RA Capital Management, L.P., The Baupost Group, -, Foresite Capital, The Pritzker Organization, Baillie Gifford and NXT Ventures

I

Intarcia Therapeutics, Inc. raised $75M on May 7, 2016

Investors: MidCap Financial

I

Intarcia Therapeutics, Inc. raised $200M on April 1, 2014

Investors: Farallon Capital Management, -, Quadrille Capital, Foresite Capital, RA Capital Management, L.P. and New Leaf Venture Partners

I

Intarcia Therapeutics, Inc. raised $160M on November 16, 2012

Investors: Venrock, Farallon Capital Management, Marker LLC, The Baupost Group, New Leaf Venture Partners and GGV Capital

FAQ